Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001628280-25-027208

Chief Medical Officer returned 1,801 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Podnos Yale Chief Medical Officer 2025-05-21 Returned to the company −1,801 $2.68 $4,818 234,336 D
Loading xslF345X05/wk-form4_1747937825.xml…